Your browser doesn't support javascript.
loading
Targeting the cancer lesion, not the whole prostate.
Bedi, Nishant; Reddy, Deepika; Ahmed, Hashim U.
Afiliação
  • Bedi N; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Reddy D; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Ahmed HU; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Transl Androl Urol ; 9(3): 1518-1525, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32676439
ABSTRACT
Modern cancer treatment aims to conserve as much healthy tissue as possible. This has been challenging in the treatment of prostate cancer due to the difficulty in imaging the gland and concerns over leaving multifocal cancer untreated. With improvements in imaging and understanding of multifocal prostate cancer evidence now shows accurate treatment of just the primary focus of cancer or the index lesion can control progression or recurrence of the disease. Many different energy sources are now available to target the cancer lesion within the prostate with less significant side-effects on urinary and sexual function compared to radical treatment. Evidence shows that men value these functions highly and would even trade years of life in exchange for preserved retention of continence or erectile function. Focal treatment of prostate cancer aims to provide both cancer control and preservation of sexual and urinary functions so that men do not have to make a choice between the two. This is a treatment option that men clearly want and deserve.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article